These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Visual impairment due to optic neuropathy in 2 patients on amiodarone therapy, i.e. ethambutol and isoniazide]. Polak BC; Tutein Nolthenius PA; Rietveld E Ned Tijdschr Geneeskd; 2001 May; 145(19):922-6. PubMed ID: 11387869 [TBL] [Abstract][Full Text] [Related]
9. Visual-field loss with optic nerve drusen and ocular hypertension: a case report. Spalding JM Optometry; 2002 Jan; 73(1):24-32. PubMed ID: 12363235 [TBL] [Abstract][Full Text] [Related]
11. [Ocular manifestation in amiodarone toxicity--case report]. Bratulescu M; Zemba M; Gheorghieva V; Andrei S; Cucu B; Dobrescu N Oftalmologia; 2005; 49(4):18-23. PubMed ID: 16524119 [TBL] [Abstract][Full Text] [Related]
12. Bilateral optic neuropathy and permanent loss of vision after treatment with amiodarone. Kervinen M; Falck A; Hurskainen M; Hautala N J Cardiovasc Pharmacol; 2013 Oct; 62(4):394-6. PubMed ID: 23921312 [TBL] [Abstract][Full Text] [Related]
13. Polypharmacy and the lack of oculo-visual complaints from those with mental illness and dual diagnosis. Donati RJ; Maino DM; Bartell H; Kieffer M Optometry; 2009 May; 80(5):249-54. PubMed ID: 19410230 [TBL] [Abstract][Full Text] [Related]
17. [Ocular findings associated to the use of amiodarone]. Riihelä K; Mäntyjärvi M Duodecim; 1996; 112(9):766-71. PubMed ID: 10592960 [No Abstract] [Full Text] [Related]